ARQT - Arcutis Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.00
DETAILS
HIGH:
$34.00
LOW:
$34.00
MEDIAN:
$34.00
CONSENSUS:
$34.00
UPSIDE:
19.63%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 90.2% |
| EBIT Margin | -0.8% |
| EBITDA Margin | 0.7% |
| Operating Margin | -3.3% |
| Pretax Margin | -4.0% |
| Cont. Ops Margin | -4.3% |
| Net Margin | -4.3% |
| Bottom Line Margin | -4.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.17 |
| Quick Ratio | 2.99 |
| Solvency Ratio | -0.044 |
| Cash Ratio | 0.33 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-223.38
Peers avg: 36.4
|
| PEG Ratio | 2.52 |
| Forward PEG | 2.52 |
| Price/Book | 19.50 |
| Price/Sales | 9.82 |
| Price/FCF | -585.47 |
| Price/Op Cash Flow | -656.87 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0145 |
| Debt/Equity | 0.0331 |
| Debt/Capital | 0.0320 |
| Long-Term Debt/Capital | 0.0270 |
| Financial Leverage | 2.29 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.40 |
| Operating Cash Flow Ratio | -0.043 |
| Operating Cash Flow/Sales | -1.5% |
| Free Cash Flow/Operating Cash Flow | 112.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.10 |
| Interest Coverage | -1.0119 |
| Short-Term Operating Cash Flow Coverage | -5.62 |
| Operating Cash Flow Coverage | -0.90 |
| Capital Expenditure Coverage | -8.20 |
| Dividend + Capital Expenditure Coverage | -8.20 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.96 |
| EPS | -0.127 |
| Debt/Share | 0.1442 |
| Cash/Share | 1.74 |
| Book Value/Share | 1.49 |
| Tangible BV/Share | 1.37 |
| Equity/Share | 1.49 |
| Operating Cash Flow/Share | -0.044 |
| Capital Expenditure/Share | 0.005 |
| FCF/Share | -0.050 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.078 |
| Earnings Before Tax/EBIT | 1.224 |
| Price/Fair Value | 19.50 |
| Debt/Market Cap | 0.0017 |
| Effective Tax Rate | -7.8% |
| Enterprise Value Multiple | 1475.09 |